Larsen & Toubro Limited vs Regeneron Pharmaceuticals, Inc.
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
Larsen & Toubro Limited
$66.5B
์์ #241
Regeneron Pharmaceuticals, Inc.
$68.6B
์์ #236
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- Larsen & Toubro Limited์ด(๊ฐ) 2004๋ ๊น์ง Regeneron Pharmaceuticals, Inc.์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Regeneron Pharmaceuticals, Inc.์ด(๊ฐ) 2012๋ ๊น์ง Larsen & Toubro Limited์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | Larsen & Toubro Limited | Regeneron Pharmaceuticals, Inc. | ์ ๋ |
|---|---|---|---|
| 2026 | $66.5B | $68.6B | Regeneron Pharmaceuticals, Inc. |
| 2025 | $66.8B | $79.3B | Regeneron Pharmaceuticals, Inc. |
| 2024 | $58.4B | $72.8B | Regeneron Pharmaceuticals, Inc. |
| 2023 | $56.7B | $89.7B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $33.1B | $73.7B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $29.7B | $64.5B | Regeneron Pharmaceuticals, Inc. |
| 2020 | $20.0B | $49.4B | Regeneron Pharmaceuticals, Inc. |
| 2019 | $19.3B | $38.4B | Regeneron Pharmaceuticals, Inc. |
| 2018 | $21.1B | $38.2B | Regeneron Pharmaceuticals, Inc. |
| 2017 | $18.2B | $38.4B | Regeneron Pharmaceuticals, Inc. |
| 2016 | $12.7B | $37.5B | Regeneron Pharmaceuticals, Inc. |
| 2015 | $11.9B | $55.5B | Regeneron Pharmaceuticals, Inc. |
| 2014 | $13.8B | $41.9B | Regeneron Pharmaceuticals, Inc. |
| 2013 | $9.8B | $28.1B | Regeneron Pharmaceuticals, Inc. |
| 2012 | $9.6B | $17.5B | Regeneron Pharmaceuticals, Inc. |
| 2011 | $5.9B | $5.7B | Larsen & Toubro Limited |
| 2010 | $11.6B | $3.4B | Larsen & Toubro Limited |
| 2009 | $9.8B | $2.5B | Larsen & Toubro Limited |
| 2008 | $4.5B | $1.9B | Larsen & Toubro Limited |
| 2007 | $12.0B | $2.5B | Larsen & Toubro Limited |
| 2006 | $4.1B | $2.1B | Larsen & Toubro Limited |
| 2005 | $2.6B | $1.6B | Larsen & Toubro Limited |
| 2004 | $1.4B | $941.1M | Larsen & Toubro Limited |
| 2003 | $1.4B | $1.5B | Regeneron Pharmaceuticals, Inc. |
| 2002 | $576.7M | $1.9B | Regeneron Pharmaceuticals, Inc. |